| NTRN recently launched its wholly owned subsidiary Nanosphere Technologies Inc. to bring together world class technology experts to assist, incubate and accelerate emerging technologies with global commercialization potential. Dr. Uri Sagman will be providing strategic counsel on numerous technology in licensing, acquisition and investment opportunities. Dr. Sagman is the co-founder and Executive Director of the Canadian Nano Business Alliance, an association dedicated to the promotion of the nanotechnology sector in Canada. The Canadian Nano Business Alliance has a diverse membership, which includes representation of government agencies, academic centers of excellence, industry and the investment community. Dr. Sagman is cofounder and President of C Sixty Inc,. At C Sixty, Dr. Sagman recruited some of the world's leading scientists, including the 1996 Nobel Prize awardee and co-discoverer of fullerenes, to advance the development of fullerene-based technology for biomedical applications. To that end, Dr. Sagman has enlisted a comprehensive R&D network, based at leading academic centers, which include Rice University, UCLA, Columbia University, Dartmouth University, the University of Toronto, Erlangen University in Germany, and the University of Taiwan. Dr. Sagman is the Chairman of GRN Health International Inc., a globally based academic research organization dedicated to medical research and development. Dr. Sagman is currently engaged in the development of strategies for National Nanotechnology Initiative programs in several countries, specializing in the development of paradigms for public and private sector alliances. In addition, Dr. Sagman's efforts are focused on the application of nanotechnology for problems of global scope. Dr. Sagman is a medical oncologist, a fellow of the Royal College of Physicians and Surgeons of Canada, and a fellowship recipient of the Medical Research Council of Canada. He is a recognized researcher in the field of clinical oncology, tumour biology and immunology. Dr. Sagman obtained his training at McGill University, The University of Calgary, The University of Toronto and Oxford University. Dr. Sagman is the recipient of numerous awards and citations including the Young Investigator awards of the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR). He has organized and participated as keynote speaker at numerous nanotechnology-based conferences. Dr. Sagman has been extensively profiled in numerous journal and press publications, including Time Magazine, Newsweek, the Economist, the New York Times, Red Herring, Technology Review, Chemical Engineering, the National Post, the Houston Chronicle, and The Toronto Star amongst others. |